|
Thu, Jul. 24, 2008
|
Michael J. Fox Foundation
|
The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces the launch of its annual Therapeutics Development Initiative (TDI) for 2008. This funding program seeks to support preclinical development of Parkinson's disease therapies which have the potential for fundamentally altering disease course and/or improving treatment of symptoms above and beyond current standards of care. Proposals must focus on key and critical preclinical studies necessary for developing, optimizing and evaluating therapeutic strategies that if successful can move into human testing.
In addition to supporting industry-led projects, the 2008 TDI program has been designed to include a track to stimulate preclinical research where the coordinating Principal Investigator is at a non-profit ('Academic') institution. Investigators from both tracks may seek up to two years of funding for preclinical development and testing of novel therapeutic approaches for the treatment or prevention of Parkinson's disease.
Please note that pre-proposals are mandatory and will be used to evaluate your proposal's fit with the stated aims and review criteria of the RFP. All pre-proposals received in response to this program will be subjected to a triage process and only those pre-proposals deemed to be of suitable scientific merit will be invited to submit a full application. Please visit the Foundation's Web site, www.michaeljfox.org, for access to this RFP and instructions for submitting a pre-proposal online. We will not accept pre-proposal submissions by email.
Academic Track:
Release Date: April 1, 2008
Conference Call: April 21, 2008 - 12pm U.S. EST **
Pre-Proposal Receipt Date: May 28, 2008 - 6pm U.S. EST
Full Application Invitation: June 12, 2008
Application Receipt Date: July 24, 2008 - 6 pm U.S. EST
Anticipated Award Announcement: October 2008
Anticipated Funding: November 2008
Industry Track:
Release Date: April 1, 2008
Conference Call: April 22, 2008-12pm U.S. EST **
Pre-Proposal Receipt Date: May 28, 2008 - 6pm U.S. EST
Full Application Invitation: June 12, 2008
Application Receipt Date: August 7, 2008 - 6pm U.S. EST
Anticipated Award Announcement: October 2008
Anticipated Funding: November 2008
**MJFF will hold conference calls to explain the Therapeutics Development Initiative and answer applicant questions. To participate in the call for either the Academic or Industry Track, you must RSVP via email to conferencecalls@michaeljfox.org. Participants will receive a reply with call-in details.
Please share this announcement with any researchers you think may be interested in this program, and please do not hesitate to contact MJFF at research@michaeljfox.org with your questions about the RFP.
|
|
Fri, Sep. 5, 2008
|
American Lung Association
|
Applications are currently available for the American Lung Association’s Nationwide Research Program 2009-2010. The deadline for submitting applications is September 5, 2008. After peer review, applicants will be notified of outcome results in February 2009.
For more information on the American Lung Association Nationwide Research Program click here or go to https://proposalcentral.altum.com to apply directly.
The mission of the American Lung Association is to prevent lung disease and promote lung health.
For the American Lung Association nearest you, contact 1-800-LUNGUSA or visit www.lungusa.org.
© 2008 American Lung Association®. All rights reserved. Privacy Policy, Ethics Policy and Terms of Use.
American Lung Association®
61 Broadway
New York, NY 10006
Contact Us
|
